| Literature DB >> 23171372 |
Haili Zhang1, Fengguang Guo, Huaijun Zhou, Guan Zhu.
Abstract
BACKGROUND: Cryptosporidium parvum is a globally distributed zoonotic parasite and an important opportunistic pathogen in immunocompromised patients. Little is known on the metabolic dynamics of the parasite, and study is hampered by the lack of molecular and genetic tools. Here we report the development of the first Agilent microarray for C. parvum (CpArray15K) that covers all predicted ORFs in the parasite genome. Global transcriptome analysis using CpArray15K coupled with real-time qRT-PCR uncovered a number of unique metabolic features in oocysts, the infectious and environmental stage of the parasite.Entities:
Mesh:
Year: 2012 PMID: 23171372 PMCID: PMC3542205 DOI: 10.1186/1471-2164-13-647
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Correlation plots of signal intensities (means of normalized median signals) between Cy3 and Cy5 dye swaps (R=0.9879) (A) and biological replicates (R=0.9886) (B). In panel B, data for replicates 1 and 2 were derived from 0.5 h and 5 h groups, each including two untreated controls and two UV-irradiation samples (oocysts) that were allowed to recover for 0.5 h or 5 h, respectively.
Figure 2Evaluation of inter-array variations by plotting of the mean signal intensities with standard deviations (SDs) of all individual probes among all 8 microarrays, and inter-probe variations by plotting the means and SDs of all individual genes from multiple probes (inset).
Figure 3Validation of microarray data by real-time qRT-PCR for selected genes. (A) Relative mRNA levels of C. parvum genes in the oocyst stage. Microarray signals are shown as the means of normalized signals derived from all probes in all 8 arrays (left axis). Levels determined by semi-qRT-PCR are displayed as the fold differences in relative to the mean of all samples in at least three biological replicates (right axis). (B) Fold changes of the gene expressions in C. parvum oocysts recovered for 30 min after UV-treatment. Bars indicate standard deviations (SDs).
Figure 4Features of expressed genes in the . oocysts (Group I genes) as determined by microarray analysis. (A) Categorization of expressed Group I genes by major functional groups. (B) Functional categorization of Group I genes by expression levels (by quartiles) in comparison with the lowly or unexpressed Group II genes.
Feature summary of the top 10% highest expressed genes in the oocysts*
| | | | | |
| | Glycolytic enzymes | cgd7_480 | Lactate dehydrogenase (LDH) | 3,064.62 |
| | Membrane remodeling | cgd8_1150 | Choline-phosphate cytidylyltransferase | 185.50 |
| | Nucleotide metabolic enzymes | cgd5_1470 | Nucleoside-diphosphate kinase domain | 1,562.52 |
| | Peptidase, kinase, phosphatase | cgd7_4790 | Ptc7p phosphatase (PP2C family) | 333.12 |
| lscU-like, F-ATPase headpiece | cgd2_1360 | Mitochondrial ATP synthase β-chain | 351.08 | |
| ABC, ion, nutrients, V-type | cgd3_510 | Putative fucose translocator | 398.70 | |
| | | | | |
| | DnaJ, HSP20, HSP90 | cgd3_3770 | HSP90 | 1,229.35 |
| | Glutaredoxin/thioredoxin related | cgd2_2540 | Glutaredoxin related protein | 250.42 |
| Microfilament elements | cgd5_3160 | Actin | 475.92 | |
| All mucin-like proteins | cgd2_430 | Mucin-like glycoprotein | 1,732.54 | |
| Cyclin family protein | cgd7_3780 | Cyclin | 318.54 | |
| | | | | |
| | RNA Pol, transcription factors | cgd3_4150 | Cutinase negative acting protein | 315.25 |
| | Translation factors, RNA helicases, etc. | cgd1_880 | Eukaryotic initiation factor 4A | 889.38 |
| Proteosome/ubiquitin subunits | cgd1_420 | 20S proteasome beta subunit D2 | 168.66 | |
| | | | | |
| | RPL, RPS, or associated proteins | cgd3_2250 | 60S ribosomal protein L37A | 303.99 |
| | GTPase, ribonucleoprotein, etc. | cgd4_1700 | GNog1p. GTPase | 276.15 |
| Methylase, Helicase, RNA-splicing, RNA-binding, etc. | cgd7_940 | T22E16.120 SC35-like splicing factor | 871.81 | |
| Methytranferase, DNA-binding | cgd2_3070 | HMG-box protein | 425.65 | |
| | | | | |
| | Conserved domain-containing | cgd2_200 | Possible apicomplexan-specific protein | 1,742.09 |
| | Predicted membrane proteins | cgd6_780 | Predicted extracellular protein | 849.61 |
| | Hypothetical/unknown | cgd3_1570 | Unknown, possible sporozoite antigen | 1,957.29 |
* A list of genes with detailed information on the normalized expression levels, their ranks, and categories is provided in Additional file 2, Table S1.
Figure 5Illustration of the expression levels of enzymes within the glycolytic pathway and major connections in the oocysts as determined by microarray analysis. The expression levels are grouped into 5 major groups by color and size. Abbreviations: ACC, acetyl-CoA carboxylase; AceACL, acetic acid-CoA ligase (aka acetyl-CoA synthetase); ACL, fatty acid-CoA ligase (aka acyl-CoA synthetase); ADH, alcohol dehydrogenase; ADH-E, type E alcohol dehydrogenase (bifunctional); FAS1, type I fatty acid synthase; GAPDH, glyceraldehyde phosphate dehydrogenase; GBE, glycogen branching enzyme; GDBE, glycogen debranching enzyme; GDH, glycerol phosphate dyhydrogenase; HK, hexokinase; LCE, long chain fatty acyl elongase; LDH, lactate dehydrogenase; MDH, malate dehydrogenase; ME, malic-enzyme; PDC, pyruvate decarboxylase; PEPCL, phosphoenolpyruvate carboxylase; PFK, phosphofructokinase; PGI, phosphoglucose isomerase; PGK, phosphoglycerate kinase; PGM, phosphoglycerate mutase; PGluM, phosphoglucose mutase; PK, pyruvate kinase; PKS1, type I polyketide synthase; PNO, pyruvate:NADP+ oxidoreductase; T6PS-TP, trehalose 6-phosphate synthase; TIM, triosephosphate isomerase; UGGP, UDP-galactose/glucose pyrophosphorylase.
Figure 6Relative level of gene expression in the oocysts, excystated sporozoites and various intracellular developmental stages in comparison with selected genes as determined by qRT-PCR. (A) Comparison of CpLDH1 expression with 4 other glycolytic genes. All levels are relative to that of CpLDH1 in the oocysts. (B) Comparison of CpLDH1 expression with three other genes responsible for producing different organic end products. In this panel, individual genes were separately calibrated, relative to the highest level within individual genes.
Figure 7Effect of UVirradiation on the oocyst viability as determined by a qRT-PCR-based in vitro infection assay. The ID20 value was determined at 2.8 mJ/cm2.
Distribution of genes with significant changes in expressions based on their fold changes (threshold = ±1.2 fold) in the groups with 0.5 h and 5 h of recovery times after UV irradiation
| 31 | 100 | 11 | 142 | |
| 236 | 1,183 | 184 | 1,603 | |
| 6 | 77 | 27 | 110 | |
| 273 | 1,360 | 222 | 1,855 |
List of top 15 up- and 15 down-regulated genes in the two UV-treated experimental groups
| Structure | 2.479 | 1.169 | cgd8_5030 | articulin family protein, Pfs77 protein-related |
| Unknown | 2.432 | 1.079 | cgd7_3840 | conserved hypothetical protein |
| Unknown | 2.192 | 1.287 | cgd3_1410 | small hypothetical protein |
| Unknown | 2.119 | 1.068 | cgd3_2070 | hypothetical protein |
| Unknown | 2.003 | 1.074 | cgd7_990 | hypothetical protein |
| Unknown | 1.985 | 1.032 | cgd1_840 | conserved hypothetical protein |
| Unknown | 1.057 | 1.968 | cgd7_2980 | low complexity protein with C2C2 zinc ribbon |
| Redox homeostasis | 1.861 | 0.987 | cgd8_3510 | thioredoxin-like protein, fragment |
| Unknown | 1.860 | 1.111 | cgd7_270 | conserved hypothetical protein |
| Enzyme | 1.845 | 1.142 | cgd3_3320 | putative phenylalanyl-tRNA synthetase |
| Unknown | 1.032 | 1.831 | cgd2_1040 | flavohemoprotein b5+b5R (DJ676J13.1), putative |
| Unknown | 1.808 | 1.068 | cgd3_270 | hypothetical protein |
| Unknown | 1.808 | 1.089 | cgd4_4030 | hypothetical protein |
| Unknown | 1.786 | 1.127 | cgd7_4710 | conserved hypothetical protein |
| Unknown | 1.782 | 1.074 | cgd3_220 | hypothetical protein |
| Unknown | 1.180 | 0.543 | cgd5_4270 | hypothetical protein, signal peptide & TM domain |
| Unknown | 1.098 | 0.589 | cgd6_4430 | hypothetical protein |
| Unknown | 1.086 | 0.587 | cgd2_4060 | hypothetical protein, 12 transmembrane domains |
| Enzyme | 1.005 | 0.595 | cgd4_960 | phosphomannomutase |
| Unknown | 0.979 | 0.549 | cgd6_290 | hypothetical protein |
| Unknown | 0.974 | 0.552 | cgd5_260 | hypothetical protein |
| Enzyme | 0.856 | 0.591 | cgd6_4020 | phosphdiesterase, putative |
| RNA metabolism | 0.594 | 0.946 | cgd6_410 | Sgn1p-like RRM domain containing protein |
| Unknown | 0.591 | 1.040 | cgd6_1100 | signal peptide-containing protein |
| Unknown | 0.590 | 0.776 | cgd6_4260 | Low complexity protein |
| Unknown | 0.582 | 1.260 | cgd8_2760 | conserved hypothetical protein |
| Unknown | 0.577 | 0.850 | cgd7_10 | hypothetical protein |
| Enzyme | 0.529 | 0.965 | cgd1_3290 | carboxylesterase, putative |
| Unknown | 0.516 | 1.091 | cgd7_1290 | hypothetical protein containing a signal peptide |
| Unknown | 0.329 | 1.117 | cgd1_1690 | PHD finger containing protein |
Functional categorization of significantly regulated genes in the oocysts upon UV irradiation
| 2 | 25 | 0 | 15 | 149 | 16 | 0 | 19 | 1 | 227 | 12.24 | |
| 0 | 18 | 0 | 2 | 65 | 2 | 0 | 8 | 3 | 98 | 5.28 | |
| 0 | 9 | 1 | 1 | 57 | 1 | 0 | 10 | 1 | 80 | 4.31 | |
| 0 | 7 | 0 | 0 | 74 | 0 | 0 | 7 | 4 | 92 | 4.96 | |
| 0 | 15 | 0 | 3 | 44 | 3 | 0 | 6 | 0 | 71 | 3.83 | |
| 0 | 6 | 0 | 1 | 24 | 3 | 0 | 4 | 0 | 38 | 2.05 | |
| 2 | 9 | 0 | 0 | 33 | 1 | 0 | 2 | 0 | 47 | 2.53 | |
| 0 | 2 | 0 | 6 | 32 | 0 | 1 | 3 | 0 | 44 | 2.37 | |
| 2 | 4 | 0 | 0 | 16 | 2 | 0 | 1 | 0 | 25 | 1.35 | |
| 1 | 2 | 0 | 2 | 18 | 2 | 0 | 2 | 0 | 27 | 1.46 | |
| 0 | 5 | 0 | 1 | 7 | 0 | 0 | 1 | 0 | 14 | 0.75 | |
| 1 | 4 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 17 | 0.92 | |
| 0 | 2 | 0 | 0 | 12 | 1 | 0 | 1 | 0 | 16 | 0.86 | |
| 0 | 4 | 0 | 0 | 5 | 0 | 0 | 1 | 1 | 11 | 0.59 | |
| 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 4 | 0.22 | |
| 8 | 112 | 1 | 32 | 550 | 31 | 1 | 66 | 10 | 811 | 43.72 | |
| 23 | 124 | 5 | 68 | 633 | 46 | 10 | 118 | 17 | 1044 | 56.28 | |
| 31 | 236 | 6 | 100 | 1183 | 77 | 11 | 184 | 27 | 1855 | 100.00 |
Note: Up = up-regulated (fold changes >1.2), Mid = less significantly regulated “middle” group (fold changes between 0.8 to 1.2), Down = down-regulated (fold changes <0.8).